Marc Pittman

453 total citations
9 papers, 353 citations indexed

About

Marc Pittman is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Marc Pittman has authored 9 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Marc Pittman's work include PARP inhibition in cancer therapy (4 papers), Glioma Diagnosis and Treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). Marc Pittman is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Glioma Diagnosis and Treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). Marc Pittman collaborates with scholars based in United Kingdom and United States. Marc Pittman's co-authors include R. S. Jones, E Gross, Robert M. Beazley, J P Grant, J A Tangrea, John H. Brown, Lisa Godfrey, Michelle Maher, Christopher E. Cox and Laurence Dunn and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Clinical Nutrition.

In The Last Decade

Marc Pittman

8 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Pittman United Kingdom 8 139 133 108 86 65 9 353
Caroline Archer United Kingdom 11 124 0.9× 244 1.8× 98 0.9× 25 0.3× 159 2.4× 21 522
Stefanie Stepanow Germany 7 132 0.9× 44 0.3× 50 0.5× 114 1.3× 22 0.3× 11 351
Diane M. Pierson United States 9 111 0.8× 29 0.2× 61 0.6× 40 0.5× 48 0.7× 11 324
Hakim Ouled‐Haddou France 13 116 0.8× 51 0.4× 15 0.1× 75 0.9× 69 1.1× 30 357
Beatriz Sánchez-Vega Spain 12 78 0.6× 93 0.7× 97 0.9× 83 1.0× 36 0.6× 18 421
Tetsuhiro Soeda Japan 15 203 1.5× 60 0.5× 58 0.5× 356 4.1× 32 0.5× 37 1.1k
Fuyumi Yamamoto Japan 8 207 1.5× 70 0.5× 55 0.5× 14 0.2× 231 3.6× 8 591
J Gidáli Hungary 10 142 1.0× 114 0.9× 17 0.2× 109 1.3× 35 0.5× 38 443
Paula Fernández‐Calotti Argentina 11 145 1.0× 65 0.5× 21 0.2× 47 0.5× 20 0.3× 17 396
Shervin Karimpour United States 8 139 1.0× 128 1.0× 21 0.2× 36 0.4× 64 1.0× 11 483

Countries citing papers authored by Marc Pittman

Since Specialization
Citations

This map shows the geographic impact of Marc Pittman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Pittman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Pittman more than expected).

Fields of papers citing papers by Marc Pittman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Pittman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Pittman. The network helps show where Marc Pittman may publish in the future.

Co-authorship network of co-authors of Marc Pittman

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Pittman. A scholar is included among the top collaborators of Marc Pittman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Pittman. Marc Pittman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Berry, Philip, Julie Errington, Philip D. Jeffrey, et al.. (2021). Development of a Lc–Ms/Ms Method for the Quantification of Toxic Payload Dm1 Cleaved from Bt1718 in a Phase I Study. Bioanalysis. 13(2). 101–113. 26 indexed citations
2.
Hanna, Catherine, Kathreena M. Kurian, Karin Williams, et al.. (2020). Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro-Oncology. 22(12). 1840–1850. 98 indexed citations
3.
Cook, Natalie, Udai Banerji, JEFF EVANS, et al.. (2019). Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours. Annals of Oncology. 30. v174–v174. 16 indexed citations
4.
Banerji, Udai, Natalie Cook, T.R. Jeffry Evans, et al.. (2018). A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.. Journal of Clinical Oncology. 36(15_suppl). TPS2610–TPS2610. 10 indexed citations
5.
Chalmers, Anthony J., Susan Short, Colin Watts, et al.. (2018). Phase I clinical trials evaluating olaparib in combination with radiotherapy (RT) and/or temozolomide (TMZ) in glioblastoma patients: Results of OPARATIC and PARADIGM phase I and early results of PARADIGM-2.. Journal of Clinical Oncology. 36(15_suppl). 2018–2018. 26 indexed citations
6.
Chalmers, Anthony J., Garth Cruickshank, Laurence Dunn, et al.. (2017). ACTR-16. RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM). Neuro-Oncology. 19(suppl_6). vi4–vi4. 14 indexed citations
7.
Halford, Sarah, Garth Cruickshank, Laurence Dunn, et al.. (2017). Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM).. Journal of Clinical Oncology. 35(15_suppl). 2022–2022. 28 indexed citations
8.
Grant, J P, Marc Pittman, Michelle Maher, & R. S. Jones. (1982). Parenteral nutrition in the management of enterocutaneous fistulas. Clinical Nutrition. 1(6). 125–125.
9.
Grant, J P, Christopher E. Cox, Michelle Maher, et al.. (1977). Serum hepatic enzyme and bilirubin elevations during parenteral nutrition.. PubMed. 145(4). 573–80. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Archer Breakdown of academic impact, for papers by Stefanie Stepanow Breakdown of academic impact, for papers by Diane M. Pierson Breakdown of academic impact, for papers by Hakim Ouled‐Haddou Breakdown of academic impact, for papers by Beatriz Sánchez-Vega Breakdown of academic impact, for papers by Tetsuhiro Soeda Breakdown of academic impact, for papers by Fuyumi Yamamoto Breakdown of academic impact, for papers by J Gidáli Breakdown of academic impact, for papers by Paula Fernández‐Calotti Breakdown of academic impact, for papers by Shervin Karimpour
Rankless by CCL
2026